Dyslipidemia, a “difficult brother” of diabetes! Statistics show that more than 70% of diabetic patients have dyslipidemia, and the two are often the cause and effect of each other, thus leading to a vicious cycle of the patient’s condition. In addition, atherosclerosis, coronary heart disease, fatty liver, etc. are all the results of dyslipidemia. Dyslipidemia requires aggressive lipid regulation rather than simple lipid lowering as many people mistakenly believe. For this reason, they pointed out that regular monitoring of lipid regulating efficacy and adverse reactions should be conducted during the course of drug treatment in order to adjust the dosage or change the type of drug in time to achieve the treatment goal; in addition, lipid regulating Chinese medicine is generally “Chinese and Western synthetic medicine”, and it is still necessary to prevent overdose of Western medicine. Some people are very nervous when they are told that their blood lipid level is high after physical examination, and they go to the gym every day to exercise and diet in order to lower their lipid level, but with little effect. For these people, doctors will recommend that they take medication to regulate their lipids, rather than just lowering them. People with dyslipidemia generally know that diet and lifestyle modification are important, but these methods only work for some patients, so taking lipid-regulating medications is another “must”. Dyslipidemia is a metabolic disease, mainly referring to elevated total cholesterol, triglycerides, LDL or a decrease in HDL. In recent years, with the improvement of people’s living standard, the level and rate of dyslipidemia have been “increasing”, which is insidious, gradual, progressive and systemic damage to health, and can lead to systemic atherosclerosis, especially coronary arteries. In addition, dyslipidemia is associated with hypertension, hyperglycemia, hyperuricemia, and indirectly contributes to the development of fatty liver, cholelithiasis, pancreatitis, fundus bleeding, and peripheral vascular disease. The “bad” cholesterol, namely low-density lipoprotein (LDL), is the most harmful, while high-density lipoprotein (HDL), also known as “good” cholesterol, has the effect of preventing atherosclerosis. Therefore, it is more important to regulate the ratio of ‘good’ and ‘bad’ cholesterol in the body than just lowering it! The process of taking medication: regular monitoring of lipid regulating efficacy There are many kinds of lipid regulating medications on the market today. Some of the western drugs “focus” on lowering blood cholesterol levels, such as statins, while others focus on lowering triglycerides, such as betablockers. In addition, bile acid chelating resins can lower cholesterol and triglycerides to varying degrees by blocking the absorption of cholesterol from the intestinal tract so that it can be excreted in the feces; linoleic acid and fish oil preparations can also lower cholesterol and triglycerides. As for proprietary Chinese medicines, the lipid-regulating proprietary Chinese medicines currently on sale are not strictly speaking purely proprietary Chinese medicines, but “Chinese and Western medicines”. These drugs should be used with caution in combination with statin or beta lipid regulators to avoid overdose. “They are generally suitable for patients with mild to moderate dyslipidemia, but should be taken according to medical advice. During the course of drug treatment, regular monitoring of lipid regulating efficacy and adverse reactions should be carried out to adjust the dosage or change the type of drug in time to effectively achieve the treatment goal. Age-appropriate men and women: annual lipid checkups should be performed Men over 40 years old and postmenopausal women should have their lipids checked once a year, while coronary heart disease and high-risk groups should be checked once every 3 to 6 months. For different types of dyslipidemia, they should be treated in different ways. For example, patients with primary dyslipidemia should be treated with targeted medications according to their conditions, while secondary dyslipidemia should be treated actively for their primary disorders. In addition, the goals of lipid treatment are different for different groups of people, mainly divided into the following categories: 1. Patients with coronary heart disease or peripheral atherosclerosis, who are at high risk of coronary heart disease, benefit most from lipid regulating treatment and should be actively treated with medication. 2.Patients who do not have coronary heart disease or peripheral atherosclerosis, but have other risk factors for coronary heart disease such as hypertension and diabetes in addition to dyslipidemia, should also be treated actively. 3.People who do not have coronary heart disease or peripheral atherosclerosis, and do not have other risk factors for coronary heart disease other than dyslipidemia, can first carry out non-pharmacological treatment, i.e., improve lifestyle, diet adjustment, moderate exercise, quit smoking and alcohol, and lose weight, and if the effect is not good, drug treatment can be given again.